Physician profile
Sean Dustin Willis
NPI 1710484910
$4,883.24
in general payments reported to CMS, 2019-2025
15 companies · $1,014 in 2025
The $1,014 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $3,498 · 2024: $371 · 2025: $1,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,822 · Food and Beverage: $1,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,822.12 |
| Food and Beverage | $1,061.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,376.09 | 2023 | |
| Intuitive Surgical, INC. | $971.08 | 2025 | |
| Tela Bio, INC. | $153.65 | 2024 | Ovitex 2s |
| Ethicon US, LLC | $57.23 | 2024 | Mega Soft, Ethicon |
| Abiomed | $49.16 | 2023-2024 | Impella |
| Integra Lifesciences Corporation | $43.27 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Takeda Pharmaceuticals U.S.A., INC. | $42.41 | 2023 | Gattex |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $34.03 | 2024 | |
| Kls-Martin L.P. | $30.24 | 2024 | |
| Solventum Corporation | $29.13 | 2024 | V.A.C. Granufoam, Abthera Advance |
| Polynovo North America LLC | $28.13 | 2023 | |
| Getinge USA Sales, LLC | $23.66 | 2023 | Vasoview Hemopro 2 |
| Davol INC. | $17.38 | 2024 | Phasix Mesh |
| Atricure, INC. | $13.92 | 2024 | |
| Zimmer Biomet Holdings, INC. | $13.86 | 2024 | Pectus Bar Bending Forceps, Standard |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.